跳至主要内容
临床试验/NCT01356589
NCT01356589已完成不适用

Retrospective Study on Intrapatient VAriabiLity of the Hemoglobin Levels in Anemic CKD Patients in Predialysis (Stage 3-4) and Dialysis (Stage 5) Treated With MIRCERA® (RIVAL Study)

Hoffmann-La Roche33 个研究点 分布在 1 个国家目标入组 1,288 人开始时间: 2010年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
1,288
试验地点
33
主要终点
Percentage of Participants With at Least One Hemoglobin Cycling

研究概览

简要总结

This retrospective observational study will assess the incidence of hemoglobin cycling in chronic kidney disease (stage 3, 4, and 5) patients with renal anemia treated with Mircera (methoxy polyethylene glycol-epoetin beta). Data will be collected from each patient from a 9-month treatment period.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients, >/= 18 years of age
  • Chronic kidney disease in predialysis (stage 3 and 4) and dialysis
  • Renal anemia treated with Mircera according to label for at least 9 months before date of signed informed consent

排除标准

  • Participation in an interventional clinical trial within the retrospective observation period
  • Contraindications to Mircera administration as per label or judged by the investigator

结局指标

主要结局

Percentage of Participants With at Least One Hemoglobin Cycling

时间窗: 9 months

Hemoglobin cycling was defined as 1 or more cycles of oscillation in hemoglobin with an amplitude of greater than or equal to (\>=) 1.5 gram per deciliter (g/dL) and a duration \>=8 weeks.

次要结局

  • Percentage of Participants With Type 2 Diabetes Who Experienced at Least 1 Hemoglobin Cycling(9 months)
  • Number of Full Hemoglobin Cycles Per Participant(9 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (33)

Loading locations...

相似试验